Epistem preliminary Results to the 30th June 2009

6th October 2009

Epistem preliminary Results to the 30th June 2009

Epistem Plc (LSE: EHP), the rapidly growing UK biotechnology company, announced today its preliminary results for the period to the 30 June 2009.

The 2008/09 financial year saw Epistem continue to build on last year's outstanding performance. The year's results saw an impressive 92% increase in year-on-year turnover and a maiden after tax profit for the Company.
Highlights of the year included a 20% growth of Contract Research Services, Biomarker sales growth and maiden divisional profit and announcement of a Regenerative Medicine collaboration with Novartis AG.

http://qq.axl.co.uk/axl-dlls/getnewsarticle?UNIQUE_ID=RNC000411200910060230&CLIENT=templates/ir/epistem/news_common.cnf